Skip to main content


Page 3 of 6

  1. Estrogen therapy in early menopausal women decreases the risk of coronary heart disease and parenteral, but not oral, estrogen is reported to reduce blood pressure (BP). Progestogens are typically added to est...

    Authors: Byung-Koo Yoon, Jidong Sung, Yun-Mi Song, Soo-Min Kim, Kyung-A Son, Jun Hyun Yoo, Sung-Ji Park and Duk-Kyung Kim
    Citation: Clinical Hypertension 2021 27:18
  2. The prevalence of hypertension is increasing in Bangladesh, however, few recent studies investigated the proportion of people and factors associated with prevalence, awareness, and control of this condition in...

    Authors: Gulam Muhammed Al Kibria, Rajat Das Gupta and Jannatun Nayeem
    Citation: Clinical Hypertension 2021 27:17
  3. The aim of this study was to examine left ventricular (LV) function in untreated, newly diagnosed hypertensive patients with morning blood pressure surge (MBPS) status using three-dimensional (3D) speckle trac...

    Authors: Ami Kwon, Sang Hyun Ihm and Chan Seok Park
    Citation: Clinical Hypertension 2021 27:16
  4. It is most important to measure blood pressure (BP) exactly in treating hypertension. Recent recommendations for diagnosing hypertension clearly acknowledge that an increase in BP attributable to the “whitecoa...

    Authors: Cheol Ho Lee, Ji Hun Ahn, Joon Ha Ryu and Woong Gil Choi
    Citation: Clinical Hypertension 2021 27:15
  5. Coronary artery ectasia (CAE) is characterized by the enlargement of a coronary artery to 1.5 times or more than other non-ectasia parts of the vessel. It is important to investigate the association of differe...

    Authors: Mostafa Bahremand, Ehsan Zereshki, Behzad Karami Matin, Mansour Rezaei and Hamidreza Omrani
    Citation: Clinical Hypertension 2021 27:14
  6. Hypertension (HTN) is a risk factor for cardiovascular disease; therefore, it is imperative to risk stratify potential kidney donors during evaluation. Clinic blood pressure (CBP) measurement is inaccurate in ...

    Authors: Nabeel Aslam, Sobia H. Memon, Hani Wadei, Elizabeth R. Lesser and Shehzad K. Niazi
    Citation: Clinical Hypertension 2021 27:13
  7. Isolated systolic hypertension typically occurs in young males; however, its clinical significance is unknown. Given the prevalence of the hypertension and its contribution to global morbidity and mortality, a...

    Authors: Holly Scott, Matthew J. Barton and Amy N. B. Johnston
    Citation: Clinical Hypertension 2021 27:12
  8. There have been concerns regarding the safety of renin-angiotensin-aldosterone-system (RAAS)-blocking agents including angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) du...

    Authors: Si-Hyuck Kang, Dong-Hoon Lee, Kyung-Do Han, Jin-Hyung Jung, Sang-Hyun Park, Andrew M. Dai, Henry G. Wei, Chang-Hwan Yoon, Tae-Jin Youn, In-Ho Chae and Cheol-Ho Kim
    Citation: Clinical Hypertension 2021 27:11
  9. Arterial stiffness is associated with myocardial ischemia and incident coronary artery disease (CAD), and indexes of arterial stiffness are usually increased in patients with CAD. However, these indexes are of...

    Authors: Seong Taeg Kim, Yeekyoung Ko, Jong-Wook Beom, Ki Yung Boo, Jae-Geun Lee, Joon-Hyouk Choi, Song-Yi Kim and Seung-Jae Joo
    Citation: Clinical Hypertension 2021 27:5
  10. BENEFIT-KOREA (BEnefits after 24 weeks of NEbivolol administration For essential hypertensIon patients wiTh various comorbidities and treatment environments in Korea) study, an observational study in South Kor...

    Authors: Kyoung Im Cho, Dong Woon Jeon, Hyo Seung Ahn, Dong Kyu Jin, Hyun Sang Lee, Jong-Young Lee, Hong-Seok Lim, Athanasios J. Manolis, Seung-Woon Rha and Sang Won Park
    Citation: Clinical Hypertension 2021 27:9
  11. The Korean Society of Hypertension has published the Korea Hypertension Fact Sheet 2020 to provide an overview of the magnitude and management status of hypertension and their recent trends.

    Authors: Hyeon Chang Kim, So Mi Jemma Cho, Hokyou Lee, Hyeok-Hee Lee, Jongmin Baek and Ji Eun Heo
    Citation: Clinical Hypertension 2021 27:8

    The Correction to this article has been published in Clinical Hypertension 2021 27:10

  12. It is known in some studies that higher the LDL-C, the greater the risk of developing cardiovascular disease. However, studies of the causal effects between LDL-C and hypertension are limited by their observat...

    Authors: Tae-Hwa Go, Kyeong Im Kwak, Ji-Yun Jang, Minheui Yu, Hye Sim Kim, Jang Young Kim, Sang Baek Koh and Dae Ryong Kang
    Citation: Clinical Hypertension 2021 27:7
  13. Previous studies that investigated association of height with prevalence and control of hypertension found mixed results. This cross-sectional study explored these associations among US adults (≥20 years).

    Authors: Rajat Das Gupta, Maxwell Akonde, Ibrahim Hossain Sajal and Gulam Muhammed Al Kibria
    Citation: Clinical Hypertension 2021 27:6
  14. Smartphone technology has spread rapidly around the globe. According to a report released by the Korea Information Society Development Institute, about 95% of Koreans aged more than 30 years old owned smartpho...

    Authors: Hae Young Lee, Dong-Ju Lee, Jongmo Seo, Sang-Hyun Ihm, Kwang-il Kim, Eun Joo Cho, Hyeon Chang Kim, Jinho Shin, Sungha Park, Il-Suk Sohn, Wook-Jin Chung, Sung Kee Ryu, Ki Chul Sung, Juhan Kim, Dae-Hee Kim and Wook Bum Pyun
    Citation: Clinical Hypertension 2021 27:4
  15. Hypertension, the most common comorbidity among coronavirus disease 2019 (COVID-19) patients, is accompanied by worse clinical outcomes, but there is lack of evidence about prognostic factors among COVID-19 pa...

    Authors: Ramin Hosseinzadeh, Mohammad Ali Sheikh Beig Goharrizi, Mansour Bahardoust, Akbar Ghorbani Alvanegh, Mohammad Reza Ataee, Mehdi Bagheri, Ensiyeh Shabani Navidiyan, Seyed Reza Hosseini Zijoud and Mohammad Heiat
    Citation: Clinical Hypertension 2021 27:3
  16. High dietary salt and a lack of reduced blood pressure (BP) at night (non-dipping) are risk factors for the development of hypertension which may result in end-organ damage and death. The effect of high dietar...

    Authors: Sepiso K. Masenga, Annet Kirabo, Benson M. Hamooya, Selestine Nzala, Geoffrey Kwenda, Douglas C. Heimburger, Wilbroad Mutale, John R. Koethe, Leta Pilic and Sody M. Munsaka
    Citation: Clinical Hypertension 2021 27:2
  17. Hypertension is a major public health problem and a prominent risk factor for cardiovascular diseases. However, whether passive smoking exposure (PSE) is associated with the risk of hypertension is scarcely un...

    Authors: Onoja Matthew Akpa, Akinkunmi Paul Okekunle, Jeffery Osahon Asowata and Babatunde Adedokun
    Citation: Clinical Hypertension 2021 27:1
  18. Although recent hypertension guidelines recommend home blood pressure (HBP) monitoring, its effect in clinical practice is not well known. This study aimed to identify current HBP measurement status and obstac...

    Authors: Jung-Yeon Choi, Kwang-il Kim and Cheol-Ho Kim
    Citation: Clinical Hypertension 2020 26:24
  19. Globally hypertension in adults is among the leading preventable cause of premature death, where a graded association from the childhood hypertension is well recognised. With the concurrent rise in obesity and...

    Authors: Mohd Ashraf, Mohd Irshad and Nazir Ahmed Parry
    Citation: Clinical Hypertension 2020 26:22
  20. According to the last Hypertension guideline recommendations, it may be concluded that intensive BP lowering is only advisable in a subgroup of patients where there is a clear net benefit of targeting to lower...

    Authors: Miguel Camafort, Josep Redón, Wook Bum Pyun and Antonio Coca
    Citation: Clinical Hypertension 2020 26:21
  21. The risk associated with serum uric acid (SUA) levels when within the normal range is unknown. This study aims to examine whether SUA within the normal range is a predictor of hypertension.

    Authors: Ryuichi Kawamoto, Daisuke Ninomiya, Taichi Akase, Kikuchi Asuka and Teru Kumagi
    Citation: Clinical Hypertension 2020 26:20
  22. This study was aimed at determining the levels of serum adiponectin, leptin, resistin, visfatin and lipids during the first trimester in pregnant women and to evaluate the relationship between these biochemica...

    Authors: Ahmed Tijani Bawah, Francis Agyemang Yeboah, Salifu Nanga, Huseini Alidu and Robert A. Ngala
    Citation: Clinical Hypertension 2020 26:19
  23. Pulmonary thromboembolism (PTE) is thought to usually stem from deep vein thrombosis (DVT). However, evidence of DVT could not be found in many cases. Furthermore, transient thyrotoxicosis is a rare but potent...

    Authors: Tong-Yoon Kim, Sang-Hyun Ihm, Ji Woong Roh, Sungmin Lim, Chan-Seok Park and Hee-Yeol Kim
    Citation: Clinical Hypertension 2020 26:17
  24. Preeclampsia is a complex syndrome that is considered a disorder specific to pregnancy. However, research indicates that diffuse maternal endothelial damage may persist after childbirth. On the other hand, wom...

    Authors: Kassahun Fikadu, Feleke G/Meskel, Firdawek Getahun, Nega Chufamo and Direslign Misiker
    Citation: Clinical Hypertension 2020 26:16
  25. Chronic kidney disease (CKD) is a significant comorbidity among hypertensive patients. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) have been demonstrated to be significantly associated wit...

    Authors: William K. B. A. Owiredu, Michael Appiah, Christian Obirikorang, Evans Asamoah Adu, Vincent Boima, Ernestine Kubi Amos-Abanyie, Priscilla Abena Akyaw, Eddie-Williams Owiredu and Emmanuel Acheampong
    Citation: Clinical Hypertension 2020 26:15
  26. There is current debate concerning the use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin II type 1 receptor blockers (ARBs), for hypertension management, during COVID-19 infection. Specifica...

    Authors: Craig Steven McLachlan
    Citation: Clinical Hypertension 2020 26:14
  27. Addressing chronic diseases is a challenge for healthcare systems worldwide, which have largely developed to deal with acute episodic care, rather than to provide organized care for people with age-long condit...

    Authors: Michael Ekholuenetale and Amadou Barrow
    Citation: Clinical Hypertension 2020 26:12
  28. Hyperuricemia, which has been considered as a cause of gout and nephrolithiasis has recently been suggested to be associated with hypertension, coronary heart disease, heart failure, atrial fibrillation, insul...

    Authors: Seung Jae Lee, Byeong Kil Oh and Ki-Chul Sung
    Citation: Clinical Hypertension 2020 26:13
  29. Hypertension, itself being a major chronic condition, is one of the most significant risk factors for premature cardiovascular diseases and mortality. Hypertension is responsible for 13% of global deaths and t...

    Authors: Mohammad Ziaul Islam Chowdhury, Meshbahur Rahman, Tanjila Akter, Tania Akhter, Arifa Ahmed, Minhajul Arifin Shovon, Zaki Farhana, Nashit Chowdhury and Tanvir C. Turin
    Citation: Clinical Hypertension 2020 26:10
  30. The incidence of hypertension is increasing worldwide and obesity is one of the most significant risk factors. Obesity can be defined by various anthropometric indices such as body mass index (BMI), waist-to-h...

    Authors: Ryuichi Kawamoto, Asuka Kikuchi, Taichi Akase, Daisuke Ninomiya and Teru Kumagi
    Citation: Clinical Hypertension 2020 26:9
  31. Antihypertensive drugs are one of the most widely used pharmacologic agent in the world and it is predominantly used in the elderly subjects. Pneumonia is the most common cause of death in the extremely old su...

    Authors: Sungha Park, Hae Young Lee, Eun Joo Cho, Ki Chul Sung, Juhan Kim, Dae-Hee Kim, Sang-Hyun Ihm, Kwang-il Kim, Il-Suk Sohn, Wook-Jin Chung, Hyeon Chang Kim, Sung Kee Ryu, Wook Bum Pyun and Jinho Shin
    Citation: Clinical Hypertension 2020 26:11
  32. Zonulin has been implicated in many metabolic disorders including hypertension and obesity. However, there is insufficient information about the involvement of zonulin in pregnancy induced hypertension (PIH) w...

    Authors: Ahmed Tijani Bawah, Henry Tornyi, Mohammed Mustapha Seini, Lincoln Toamsoma Ngambire and Francis Agyemang Yeboah
    Citation: Clinical Hypertension 2020 26:7
  33. Renal artery stenosis is a notorious cause of secondary hypertension which classically presents as chronic refractory hypertension, recurrent flash pulmonary edema or renal insufficiency after initiation of an...

    Authors: Michael Brandon Omar, William Kogler, Satish Maharaj and Win Aung
    Citation: Clinical Hypertension 2020 26:6
  34. Although dietary modification is strongly recommended for prevention and treatment of hypertension, little is known about which factors are associated with adherence to dietary guidelines. We investigated know...

    Authors: Jee-Seon Shim, Ji Eun Heo and Hyeon Chang Kim
    Citation: Clinical Hypertension 2020 26:5
  35. The Korean Society of Hypertension (KSH) revised the local guidelines for hypertension in 2018. The present study sought to evaluate the potential impact of the 2018 KSH guidelines on hypertension management s...

    Authors: Ju-Seung Kwun, Sun-Hwa Kim, Si-Hyuck Kang, Chang-Hwan Yoon, Hae-Young Lee, Kwang-Il Kim, Tae-Jin Youn, In-Ho Chae and Cheol-Ho Kim
    Citation: Clinical Hypertension 2020 26:3
  36. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) tends to increase with age and increase in proportion to body weight and height. Recent epidemiological and longitudinal cohort studies have fou...

    Authors: Jung Won Lee, Nameun Kim, Bohyun Park, Hyesook Park and Hae Soon Kim
    Citation: Clinical Hypertension 2020 26:2
  37. Hypertension is a leading cause of cardiovascular disease, stroke, and death. It affects a substantial proportion of the population worldwide, and remains underdiagnosed and undertreated.

    Authors: Gyu Chul Oh and Hyun-Jai Cho
    Citation: Clinical Hypertension 2020 26:1
  38. Although there has been a well-established association between overweight-obesity and hypertension, whether such associations are heterogeneous for South Asian populations, or for different socioeconomic group...

    Authors: Fariha Binte Hossain, Gourab Adhikary, Ariful Bari Chowdhury and Md Shajedur Rahman Shawon
    Citation: Clinical Hypertension 2019 25:28
  39. Hypertension control is a major public health concern. Daily preventive practices of the affected individual are essential for controlling blood pressure (BP). We investigated the association of diet managemen...

    Authors: Jee-Seon Shim, Sun Jae Jung and Hyeon Chang Kim
    Citation: Clinical Hypertension 2019 25:24
  40. The significance of high systolic and diastolic blood pressure remains controversial. We assessed the differences in prevalence of hypertension and its subtypes according to the different hypertension diagnost...

    Authors: So Mi Jemma Cho, Hokyou Lee and Hyeon Chang Kim
    Citation: Clinical Hypertension 2019 25:26
  41. 17α-hydroxylase deficiency is a rare autosomal recessive disorder caused by mutations in the cytochrome P450 family 17 subfamily A member 1 gene. The major clinical presentation includes hypertension, hypokale...

    Authors: Menglin Wang, Hao Wang, Haiying Zhao, Ling Li, Min Liu, Fujia Liu, Fansen Meng and Caini Fan
    Citation: Clinical Hypertension 2019 25:23
  42. Pulmonary arterial hypertension (PAH) is known as one of diseases with the worst prognosis. Recently, targeted PAH drugs have been developed and approved for use; therefore, the treatment strategy and goals ha...

    Authors: Kyung Jin Ahn, Albert Youngwoo Jang, Su Jung Park and Wook-Jin Chung
    Citation: Clinical Hypertension 2019 25:22
  43. Pulmonary arterial hypertension (PAH) is a progressive, chronic disease without curative treatment. Large registry data of these patient populations have been published, although, phenotypic variants within ea...

    Authors: Albert Youngwoo Jang, Sungseek Kim, Su Jung Park, Hanul Choi, Pyung Chun Oh, Seyeon Oh, Kyung-Hee Kim, Kye Hun Kim, Kyunghee Byun and Wook-Jin Chung
    Citation: Clinical Hypertension 2019 25:21

Official journal of

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.6
    5-year Journal Impact Factor: N/A
    Source Normalized Impact per Paper (SNIP): 1.109
    SCImago Journal Rank (SJR): 0.697

    Speed 2023
    Submission to first editorial decision (median days): 18
    Submission to acceptance (median days): 136

    Usage 2023
    Downloads: 400,408
    Altmetric mentions: 59